TGM2 and cranioectodermal dysplasia: Recent advancements in the pathogenesis of CeD have focused on the mechanisms through which tissue transglutaminase (the main autoantigen in CeD) deamidates certain glutamine residues of gliadin peptides, converting them into glutamic acid.